Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients

Compliance modulation of a soft robotic atrioventricular model of heart failure with preserved ejection fraction

Explore a breakthrough in HFpEF treatment: A new in-vitro simulator mimics heart function, paving way for device testing and better manageme

Optimizing Quadruple Guideline-Directed Therapy for Heart Failure with Reduced Ejection Fraction

Are you providing optimal quadruple therapy for your patients with heart failure?

Pharmacist-Led Drug Management for HFrEF Cost Effective

New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart failure with reduced

El 'biofeedback' cardíaco reduce el estrés y provoca cambios medibles en la actividad cerebral, según un estudio

Heart failure drugs show cardioprotective benefits for cancer patients undergoing treatment

The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated today in a presentation at ESC Cardio-Onc

STAT+: AstraZeneca, Ionis report major trial failure with heart disease drug

AstraZeneca and Ionis reported a notable trial failure Thursday in a heart disease that's become an increasingly competitive market for drug